{"id":"NCT03868124","sponsor":"Glaukos Corporation","briefTitle":"Clinical Study Comparing Two Models of a Travoprost Intraocular Implant","officialTitle":"Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-09-17","primaryCompletion":"2022-06-10","completion":"2024-06-19","firstPosted":"2019-03-08","resultsPosted":"2023-09-26","lastUpdate":"2024-11-29"},"enrollment":560,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Glaucoma, Open-Angle","Ocular Hypertension"],"interventions":[{"type":"COMBINATION_PRODUCT","name":"G2-TR intraocular implant containing travoprost","otherNames":["Implant Group"]},{"type":"DRUG","name":"Sham surgery + active-comparator eye drops","otherNames":["Control Group"]}],"arms":[{"label":"Implant Group 1","type":"EXPERIMENTAL"},{"label":"Implant Group 2","type":"EXPERIMENTAL"},{"label":"Control Group","type":"ACTIVE_COMPARATOR"}],"summary":"Phase III study to compare the safety and efficacy of intraocular implants containing Travoprost at two different elution rates versus Timolol Maleate Ophthalmic Solution, 0.5% (Timolol) in reducing elevated intraocular pressure in subjects with open angle glaucoma (OAG) or ocular hypertension (OHT)","primaryOutcome":{"measure":"Change From Baseline in Diurnal IOP (as Measured at 8AM and 10AM) Through 3 Months Postoperative","timeFrame":"3 Months","effectByArm":[{"arm":"Implant Group 1","deltaMin":-8.26,"sd":0.27},{"arm":"Implant Group 2","deltaMin":-8.4,"sd":0.27},{"arm":"Control Group","deltaMin":-7.16,"sd":0.26}],"pValues":[{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["39240530","38985408"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":185},"commonTop":["intraocular pressure increased","Iritis"]}}